Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karen Morris

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Journal of Molecular Endocrinology|January 27, 2021
Differential activity and expression of human 5β-reductase (AKR1D1) splice variantsNathan Appanna, Hylton Gibson, Elena Gangitano, et al.
Transfusion|July 16, 2015
Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantationTina Pham, Sushrut Patil, Shaun Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancerJian-Mei Hou, Matthew G Krebs, Lee Lancashire, et al.
The Journal of Endocrinology|February 28, 2020
Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivoNikolaos Nikolaou, Anastasia Arvaniti, Nathan Appanna, et al.
Nature Medicine|November 22, 2016
Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancerLouise Carter, Dominic G Rothwell, Barbara Mesquita, et al.
BMC Cancer|April 2, 2021
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker studyReem D Mahmood, Danielle Shaw, Tine Descamps, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Engineering Functionality Optimized fully human B7-H3 CAR T Cells for Enhanced Solid Tumor TherapyPradip Bajgain, Yang Feng, Mariela Puebla, et al.
The Lancet. Oncology|July 17, 2015
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trialJuan W Valle, Harpreet Wasan, Andre Lopes, et al.
Cell Reports. Medicine|April 30, 2026
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapyPradip Bajgain, Yang Feng, Mariela Puebla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2023
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced CancerSarah Halford, Gareth J Veal, Stephen R Wedge, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Journal of Molecular Endocrinology|January 27, 2021
Differential activity and expression of human 5β-reductase (AKR1D1) splice variantsNathan Appanna, Hylton Gibson, Elena Gangitano, et al.
Transfusion|July 16, 2015
Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantationTina Pham, Sushrut Patil, Shaun Fleming, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2012
Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancerJian-Mei Hou, Matthew G Krebs, Lee Lancashire, et al.
The Journal of Endocrinology|February 28, 2020
Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivoNikolaos Nikolaou, Anastasia Arvaniti, Nathan Appanna, et al.
Nature Medicine|November 22, 2016
Molecular analysis of circulating tumor cells identifies distinct copy-number profiles in patients with chemosensitive and chemorefractory small-cell lung cancerLouise Carter, Dominic G Rothwell, Barbara Mesquita, et al.
BMC Cancer|April 2, 2021
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker studyReem D Mahmood, Danielle Shaw, Tine Descamps, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Engineering Functionality Optimized fully human B7-H3 CAR T Cells for Enhanced Solid Tumor TherapyPradip Bajgain, Yang Feng, Mariela Puebla, et al.
The Lancet. Oncology|July 17, 2015
Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trialJuan W Valle, Harpreet Wasan, Andre Lopes, et al.
Cell Reports. Medicine|April 30, 2026
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapyPradip Bajgain, Yang Feng, Mariela Puebla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2023
A Phase I Dose-escalation Study of AZD3965, an Oral Monocarboxylate Transporter 1 Inhibitor, in Patients with Advanced CancerSarah Halford, Gareth J Veal, Stephen R Wedge, et al.
Pageof 4